Keywords: biota, six-month, profit, jumps, gsk, deal, australian
Biota's six-month profit jumps 31% on GSK deal
Article | 02 March 2009
Australian anti-infectives company Biota Holdings reported a 31% year-on-year jump in net profit for the six months ended December 2008, to A$7.2 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
